CVS Settles Medi-Cal Fraud Claims with California State

CVS Pharmacy has agreed to pay more than $18 million to settle a lawsuit with the state of California over allegations of fraudulent claims submitted to the Medi-Cal public health insurance system, according to Attorney General Rob Bonta.

The settlement resolves accusations that CVS used false electronic certifications between 2010 and 2021 to indicate patients had qualifying medical conditions for prescription drug coverage under Medi-Cal. State officials claim the pharmacy chain knowingly failed to verify or properly document required compliance for numerous claims, resulting in millions of dollars in improper payments from California’s Medicaid program.

“Today’s settlement holds CVS accountable for its fraudulent drug dispensing and billing practices,” Bonta said in a statement. “Pharmacies have an important responsibility to ensure all claims they submit to Medi-Cal are verified, true, accurate and well documented.”

The Attorney General emphasized that proper verification practices are crucial for ensuring safe and cost-effective prescription drug use while protecting Medi-Cal funds for those who genuinely need them.

The case originated from allegations made by a former CVS pharmacist who utilized the whistleblower provisions of the False Claims Act. This federal law allows private citizens with knowledge of fraud to bring civil actions on behalf of the government and share in any recovery obtained. The whistleblower claimed that CVS, motivated by expediting claim payments, recklessly submitted billing codes without conducting necessary verification and documentation.

This settlement represents a significant enforcement action in California’s ongoing efforts to combat healthcare fraud. Medi-Cal, California’s Medicaid program, provides healthcare coverage for approximately 15 million low-income residents, making it the largest state-run public health insurance program in the country. Protecting its financial integrity remains a priority for state regulators.

The $18.2 million settlement was reached through a collaborative investigation by the California Department of Justice’s Division of Medi-Cal Fraud and Elder Abuse and the U.S. Attorney’s Office for the Eastern District of California. Since Medi-Cal receives both state and federal funding, the federal government will receive 44.34% of the settlement proceeds.

CVS Pharmacy, a subsidiary of CVS Health, operates over 9,000 retail locations nationwide and is one of the largest pharmacy chains in the United States. The company has not admitted guilt to the allegations as part of the settlement agreement.

This case highlights the growing scrutiny of prescription drug billing practices across the healthcare industry. In recent years, federal and state authorities have increased enforcement actions against pharmacies, drug manufacturers, and healthcare providers for alleged fraud and improper billing practices.

For Medi-Cal and other public health insurance programs, improper claims and billing fraud represent a significant drain on resources that could otherwise be directed toward patient care. The California Department of Justice has prioritized investigations into healthcare fraud as part of broader efforts to control healthcare costs and ensure program integrity.

The settlement also underscores the important role whistleblowers play in identifying potential fraud against government healthcare programs. The False Claims Act provides financial incentives for individuals with knowledge of wrongdoing to come forward, allowing authorities to pursue cases that might otherwise remain undetected.

While the settlement resolves this specific case, it may prompt other pharmacies and healthcare providers to review their own compliance procedures to ensure they meet all requirements for public health insurance billing.